产品简要
公司名称 :
伯乐(Bio-Rad)公司
其他品牌 :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
产品类型 :
抗体
产品名称 :
MOUSE抗大鼠CD90
目录 :
MCA04G
规格 :
0.25毫克
价格 :
328美元
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
未共轭
克隆名称 :
T11D7e
反应物种 :
大鼠
应用 :
免疫细胞化学, 免疫沉淀, 流式细胞仪
更多信息或购买 :
文章摘录数: 6
出版应用/物种/样本/稀释 | 参考文献 |
---|---|
| |
| |
图像
图像 1 :
Published customer image: . Mouse anti Rat CD90 antibody, clone T11D7e ( MCA04G ) used for the identification of Thy1.1 expressing cells in Wistar Rat retinal tissue by immunofluorescence on formalin fixed, paraffin embedded sections. Image caption: . Immunohistochemistry of DPP4 in retinal sections. From: Dietrich N, Kolibabka M, Busch S, Bugert P, Kaiser U, Lin J, et al . (2016). The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy. PLoS ONE 11(12): e0167853 .
产品信息
Entity Type :
单克隆抗体
Entity Category :
抗体
ProductCode :
MCA04G
描述 :
MOUSE抗大鼠CD90
特异性 :
CD90
目标物种 :
大鼠
宿主 :
小鼠
格式 :
纯化
Isotypes :
IgM
应用 :
F, CT
ApplicationTypes :
Flow Cytometry,Cytotoxic Assays
交叉活性 :
小鼠
克隆 :
T11D7e
规格 :
0.25毫克
Quantity Value :
0.25
规格类型 :
毫克
GO登录号 :
GO:0045576, GO:0043547, GO:0046549, GO:0050731, GO:0048147, GO:0048041, GO:0050771, GO:0050852, GO:0050870, GO:0050860, GO:0051281, GO:0030426, GO:0030336, GO:0019901, GO:0034235, GO:0043066, GO:0007010, GO:0005829, GO:0006469, GO:0005100, GO:0016337, GO:0001525
GOTerms :
blood vessel formation from pre-existing blood vessels,cytoskeletal organization and biogenesis,cytoskeletal regulator activity,cytoskeleton organisation,cytoskeleton organization and biogenesis,Rho GAP activity,down regulation of protein kinase activity,downregulation of protein kinase activity,down-regulation of protein kinase activity,inhibition of protein kinase activity,down regulation of cell migration,downregulation of cell migration,down-regulation of cell migration,inhibition of cell migration,glycosylphosphatidylinositol binding,down regulation of apoptosis,downregulation of apoptosis,down-regulation of apoptosis,inhibition of apoptosis,activation of GTPase activity,stimulation of GTPase activity,up regulation of GTPase activity,upregulation of GTPase activity,up-regulation of GTPase activity,focal adhesion formation,down regulation of fibroblast proliferation,downregulation of fibroblast proliferation,down-regulation of fibroblast proliferation,inhibition of fibroblast proliferation,activation of peptidyl-tyrosine phosphorylation,stimulation of peptidyl-tyrosine phosphorylation,up regulation of peptidyl-tyrosine phosphorylation,up-regulation of peptidyl-tyrosine phosphorylation,upregulation of peptidyl-tyrosine phosphorylation,down regulation of axonogenesis,downregulation of axonogenesis,down-regulation of axonogenesis,inhibition of axonogenesis,T lymphocyte receptor signaling pathway,T lymphocyte receptor signalling pathway,T-cell receptor signaling pathway,T-cell receptor signalling pathway,TCR signaling pathway,T-lymphocyte receptor signaling pathway,T-lymphocyte receptor signalling pathway,down regulation of T cell receptor signaling pathway,downregulation of T cell receptor signaling pathway,down-regulation of T cell receptor signaling pathway,inhibition of T cell receptor signaling pathway,negative regulation of T cell receptor signalling pathway,negative regulation of T lymphocyte receptor signaling pathway,negative regulation of T lymphocyte receptor signalling pathway,negative regulation of T-cell receptor signaling pathway,negative regulation of TCR signaling pathway,negative regulation of T-lymphocyte receptor signaling pathway,negative regulation of T-lymphocyte receptor signalling pathway,activation of T cell activation,positive regulation of T lymphocyte activation,positive regulation of T-cell activation,positive regulation of T-lymphocyte activation,stimulation of T cell activation,up regulation of T cell activation,upregulation of T cell activation,up-regulation of T cell activation,activation of release of sequestered calcium ion into cytosol,positive regulation of calcium ion (Ca2+) mobilization,positive regulation of calcium mobilization,positive regulation of cytoplasmic release of sequestered calcium ion (Ca2+),positive regulation of cytoplasmic release of stored calcium ion (Ca2+),positive regulation of cytosolic release of sequestered calcium ion (Ca2+),positive regulation of cytosolic release of stored calcium ion (Ca2+),positive regulation of release of sequestered calcium ion (Ca2+),positive regulation of release of sequestered calcium ion into cytoplasm,positive regulation of release of stored calcium ion (Ca2+),positive regulation of release of stored calcium ion (Ca2+) into cytoplasm,positive regulation of release of stored calcium ion (Ca2+) into cytosol,stimulation of release of sequestered calcium ion into cytosol,up regulation of release of sequestered calcium ion into cytosol,upregulation of release of sequestered calcium ion into cytosol,up-regulation of release of sequestered calcium ion into cytosol
UniProt数据库登录号 :
P01830
基因 :
Thy1
GeneID网址 :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=24832
出版同义词 :
THY1, THY1.1
Entity Formats :
纯化
UNSPSC :
41116161
浓度 :
IgM浓度1毫克/毫升
产品形式 :
Ig fraction - liquid
PriceGBP :
252
PriceEUR :
355
PriceUSD :
328美元
PriceCHF :
386
PriceSEK :
3870
PriceNOK :
3889
PriceDKK :
2647
NotForSaleInCountries :
澳大利亚
更多信息或购买 :
公司信息
伯乐(Bio-Rad)公司
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com44-1865-852-700
公司总部: 英国
伯乐(Bio-Rad)公司是世界领先的抗体生产商之一。通过其原名为AbD Serotec公司的专业抗体业务团队,提供超过12,000种抗体及相关试剂,专注于免疫学、肿瘤、兽医研究及细胞生物学等领域。
抗体产品包括细胞凋亡试剂盒,自噬检测试剂,CD分子标记物,标签抗体,免疫学研究抗体,神经科学研究抗体和兽医应用试剂等。
伯乐(Bio-Rad)公司在英国拥有经ISO9001和ISO13485认证的生产厂房,同时在德国和美国均设有经ISO9001认证的厂房。
我们专业领域已扩展到传统和重组抗体制备及生产服务。我们的抗体定制服务仅需8周就能完成抗体制备并且成功率在90%以上。我们的体外重组抗体技术能够使得我们筛选制备针对具有挑战性的靶点的抗体,确保长期稳定供货,并能够提供抗体的相应基因序列。
伯乐(Bio-Rad)公司 致力于提供帮助您成功的抗体。我们专注于提供技术、产品及相关所有支持信息以协助您出色完成相关科学研究。
抗体产品包括细胞凋亡试剂盒,自噬检测试剂,CD分子标记物,标签抗体,免疫学研究抗体,神经科学研究抗体和兽医应用试剂等。
伯乐(Bio-Rad)公司在英国拥有经ISO9001和ISO13485认证的生产厂房,同时在德国和美国均设有经ISO9001认证的厂房。
我们专业领域已扩展到传统和重组抗体制备及生产服务。我们的抗体定制服务仅需8周就能完成抗体制备并且成功率在90%以上。我们的体外重组抗体技术能够使得我们筛选制备针对具有挑战性的靶点的抗体,确保长期稳定供货,并能够提供抗体的相应基因序列。
伯乐(Bio-Rad)公司 致力于提供帮助您成功的抗体。我们专注于提供技术、产品及相关所有支持信息以协助您出色完成相关科学研究。